Physician
Hackensack Meridian Health Medical Group - Primary Care PC
Hackensack Meridian Health Medical Group - Primary Care PC was paid $21.84M by Medicaid between Jan 2018 and Dec 2024, across 168 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 42% of everything it billed.
33Billing provider infoHACKENSACK MERIDIAN HEALTH MEDICAL GROUP - PRIMARY CARE PC
RED BANK, NJ 07701
RED BANK, NJ 07701
33aNPI1336203538assigned 12/21/2006
33bProvider typeInternal Medicine Physician
28Total paid$21.84M
24GClaims515,487
24DCodes billed168
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in New Jersey
Rank by total paid#5 of 1,027
Median peer was paid$30K
This provider vs. median734×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 38,912 | $1.30M | |
| 2019 | 57,397 | $2.04M | |
| 2020 | 44,593 | $1.78M | |
| 2021 | 55,417 | $2.49M | |
| 2022 | 58,684 | $2.70M | |
| 2023 | 128,732 | $5.34M | |
| 2024incomplete | 131,752 | $6.18M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 42% | 110,303 | 99,765 | $9.14M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 32% | 115,221 | 103,873 | $6.98M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 3.3% | 37,301 | 34,845 | $722K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 3.0% | 23,468 | 7,593 | $649K |
| 99223 | Prolong inpt eval add15 m | 2.2% | 4,519 | 3,915 | $482K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1.9% | 6,900 | 6,563 | $412K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.5% | 5,112 | 1,938 | $332K |
| 99442 | 1.3% | 5,438 | 4,832 | $286K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1.1% | 4,703 | 4,335 | $241K |
| 99222 | Initial hospital care, per day, moderate complexity | 1.0% | 3,171 | 2,715 | $221K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 3,364 | 3,220 | $209K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 4,463 | 3,834 | $191K |
156 more codes
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,718 | $187K |
| 90461 | <1% | 9,140 | $160K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,475 | $144K |
| 99460 | <1% | 2,278 | $123K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 10,370 | $103K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,101 | $101K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,369 | $90K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 932 | $86K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 1,206 | $84K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 5,964 | $68K |
| 93000 | <1% | 6,431 | $67K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 3,587 | $57K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 4,228 | $56K |
| 99443 | <1% | 993 | $50K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,335 | $48K |
| 92551 | <1% | 3,540 | $41K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,014 | $38K |
| 99441 | <1% | 1,183 | $36K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 820 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,457 | $25K |
| 96127 | <1% | 5,525 | $21K | |
| 99218 | <1% | 419 | $21K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 219 | $21K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 3,207 | $20K |
| 90686 | <1% | 6,691 | $20K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 923 | $19K |
| 90682 | <1% | 394 | $18K | |
| 99217 | <1% | 484 | $17K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 365 | $16K |
| 80305 | <1% | 1,591 | $14K | |
| 99462 | <1% | 511 | $14K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 157 | $12K |
| 93922 | <1% | 362 | $12K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 189 | $12K |
| 92552 | <1% | 533 | $9K | |
| 92587 | <1% | 426 | $9K | |
| 17110 | <1% | 78 | $9K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 102 | $7K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 89 | $7K |
| 99464 | <1% | 123 | $6K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 1,411 | $5K |
| 90677 | <1% | 438 | $5K | |
| 90670 | <1% | 1,363 | $5K | |
| 99406 | <1% | 614 | $5K | |
| 99283 | Emergency room visit (moderate) | <1% | 93 | $5K |
| 90656 | <1% | 678 | $5K | |
| 0011A | <1% | 114 | $4K | |
| 99349 | <1% | 262 | $4K | |
| 0012A | <1% | 100 | $4K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 239 | $3K |
| 99385 | <1% | 68 | $3K | |
| 90688 | <1% | 149 | $3K | |
| 99220 | <1% | 35 | $3K | |
| 99224 | <1% | 150 | $3K | |
| 0071A | <1% | 57 | $2K | |
| 99401 | <1% | 118 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $2K |
| 99173 | <1% | 1,758 | $2K | |
| 99219 | <1% | 25 | $2K | |
| 83655 | <1% | 539 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 229 | $2K |
| 99235 | <1% | 17 | $2K | |
| 99236 | Prolong inpt eval add15 m | <1% | 14 | $2K |
| 87807 | <1% | 691 | $1K | |
| 90698 | <1% | 714 | $1K | |
| 90662 | <1% | 176 | $1K | |
| 90673 | <1% | 54 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 139 | $1K |
| 0072A | <1% | 27 | $1K | |
| 0002A | <1% | 26 | $994.85 | |
| 99497 | <1% | 28 | $928.74 | |
| 99221 | <1% | 26 | $897.39 | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | <1% | 67 | $823.43 |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 29 | $811.95 |
| 87428 | <1% | 33 | $728.58 | |
| 36416 | <1% | 378 | $691.91 | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 92 | $685.64 |
| S9470 | Nutritional counseling, dietitian visit | <1% | 100 | $567.50 |
| 0240U | <1% | 14 | $546.37 | |
| 0001A | <1% | 13 | $515.88 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 12 | $499.29 |
| 69210 | <1% | 15 | $413.69 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 199 | $413.53 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 136 | $351.90 |
| 90619 | <1% | 65 | $347.47 | |
| 90756 | <1% | 13 | $301.92 | |
| 92583 | <1% | 14 | $292.32 | |
| 94375 | <1% | 56 | $281.10 | |
| 90734 | <1% | 52 | $276.54 | |
| 90651 | <1% | 23 | $272.02 | |
| 82270 | <1% | 241 | $269.49 | |
| 90671 | <1% | 88 | $262.13 | |
| 94727 | <1% | 56 | $217.66 | |
| 82948 | <1% | 158 | $206.39 | |
| 90680 | <1% | 220 | $194.95 | |
| 90674 | <1% | 13 | $189.45 | |
| 94729 | <1% | 56 | $154.83 | |
| 93016 | <1% | 13 | $150.81 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 16 | $133.15 |
| G0008 | Administration of influenza virus vaccine | <1% | 129 | $123.75 |
| 99051 | <1% | 83 | $113.00 | |
| 93018 | <1% | 13 | $109.32 | |
| 90723 | <1% | 90 | $103.97 | |
| G0136 | Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months | <1% | 13 | $101.22 |
| 82962 | <1% | 207 | $78.93 | |
| 90744 | <1% | 106 | $71.45 | |
| 94200 | <1% | 56 | $67.98 | |
| 90648 | <1% | 148 | $62.60 | |
| 11721 | <1% | 14 | $61.02 | |
| 90715 | <1% | 34 | $45.31 | |
| 81001 | <1% | 27 | $41.35 | |
| 99000 | <1% | 1,087 | $41.24 | |
| 90697 | <1% | 43 | $35.68 | |
| 81002 | <1% | 195 | $30.07 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 17,279 | $26.01 |
| 90661 | <1% | 250 | $21.21 | |
| 96160 | <1% | 14 | $18.08 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 18 | $16.31 |
| 3046F | <1% | 445 | $5.00 | |
| 1126F | <1% | 598 | $4.01 | |
| 90633 | <1% | 68 | $4.00 | |
| G9665 | Patients who are not currently statin therapy users or did not receive an order (prescription) for statin therapy | <1% | 6,159 | $2.68 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 16,013 | $2.00 |
| 90647 | <1% | 39 | $2.00 | |
| 90716 | <1% | 21 | $2.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 9,068 | $1.01 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | <1% | 4,558 | $0.54 |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | <1% | 2,632 | $0.29 |
| G9781 | Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons) | <1% | 340 | $0.13 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | <1% | 4,197 | $0.09 |
| G8938 | Bmi is documented as being outside of normal parameters, follow-up plan is not documented, documentation the patient is not eligible | 0% | 539 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 4,796 | $0.00 |
| 3050F | 0% | 584 | $0.00 | |
| 0502F | 0% | 76 | $0.00 | |
| 4004F | 0% | 202 | $0.00 | |
| 0521F | 0% | 22 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 71 | $0.00 |
| 91300 | 0% | 61 | $0.00 | |
| 90681 | 0% | 16 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 4,827 | $0.00 |
| G9717 | Documentation stating the patient has had a diagnosis of bipolar disorder | 0% | 2,642 | $0.00 |
| 3048F | 0% | 2,208 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 4,263 | $0.00 |
| 1125F | 0% | 383 | $0.00 | |
| 1036F | 0% | 1,813 | $0.00 | |
| 3049F | 0% | 949 | $0.00 | |
| 3008F | 0% | 45 | $0.00 | |
| 2000F | 0% | 422 | $0.00 | |
| 99417 | Prolong home eval add 15m | 0% | 14 | $0.00 |
| 1000F | 0% | 176 | $0.00 | |
| 2010F | 0% | 156 | $0.00 | |
| 91307 | 0% | 54 | $0.00 | |
| 1101F | 0% | 17 | $0.00 | |
| 1220F | 0% | 44 | $0.00 | |
| 3074F | 0% | 121 | $0.00 | |
| 3061F | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVARGA, DANIEL (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Hackensack Meridian Health Medical Group - Specialty Care PC | Red Bank, NJ | $50.09M |
| Hackensack Meridian Health Medical Group - Complex Care PC | Red Bank, NJ | $11.60M |
| Hackensack Meridian Health Medical Group - Specialty Care PC | Red Bank, NJ | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.